Evidence map›Paper›PMID 35305027›Full record

ArticleMedical physics2022

An original deep learning model using limited data for COVID-19 discrimination: A multicenter study.

Fangyi Xu, Kaihua Lou, Chao Chen, Qingqing Chen, Dawei Wang, Jiangfen Wu, Wenchao Zhu, Weixiong Tan, Yong Zhou, Yongjiu Liu and 8 more

Abstract readMulticenter Study
In one paragraph

Article in Medical physics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Fangyi XuDepartment of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Kaihua LouDepartment of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chao ChenDepartment of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Qingqing ChenDepartment of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Dawei WangInstitute of Advanced Research, Infervision Medical Technology Co. Ltd., Beijing, China.
Jiangfen WuInstitute of Advanced Research, Infervision Medical Technology Co. Ltd., Beijing, China.
Wenchao ZhuDepartment of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Weixiong TanInstitute of Advanced Research, Infervision Medical Technology Co. Ltd., Beijing, China.
Yong ZhouDepartment of Pulmonary and Critical Care Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yongjiu LiuDepartment of Radiology, Jingmen No.1 People's Hospital, Jingmen, China.
Bing WangDepartment of Radiology, Jingmen No.1 People's Hospital, Jingmen, China.
Xiaoguo ZhangDepartment of Respiratory Medicine, Jinan Infectious Disease Hospital, Shandong University, Jinan, China.
Zhongfa ZhangDepartment of Respiratory Medicine, Jinan Infectious Disease Hospital, Shandong University, Jinan, China.
Jianjun ZhangDepartment of Radiology, Zhejiang Hospital, Hangzhou, China.
Mingxia SunDepartment of Radiology, Zhejiang Hospital, Hangzhou, China.
Guohua ZhangDepartment of Radiology, Taizhou No.1 People's Hospital, Taizhou, China.
Guojiao DaiDepartment of Radiology, Taizhou No.1 People's Hospital, Taizhou, China.
Hongjie HuDepartment of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Funding

Beijing Bethune Charitable Foundation Run Wu You Sheng BJ-RW2020006JKey Research and Development Program of Zhejiang Province 2019C03064National Natural Science Foundation of China 82071988Program Co-sponsored by Province and Ministry WKJ-ZJ-1926Zhejiang Provincial Natural Science Foundation of China 2020XGZX051Zhejiang University special scientific research fund for COVID-19 prevention and control LQ20F030018
6 · The paper itself

Abstract

objectivesArtificial intelligence (AI) has been proved to be a highly efficient tool for COVID-19 diagnosis, but the large data size and heavy label force required for algorithm development and the poor generalizability of AI algorithms, to some extent, limit the application of AI technology in clinical practice. The aim of this study is to develop an AI algorithm with high robustness using limited chest CT data for COVID-19 discrimination.

methodsA three dimensional algorithm that combined multi-instance learning with the LSTM architecture (3DMTM) was developed for differentiating COVID-19 from community acquired pneumonia (CAP) while logistic regression (LR), k-nearest neighbor (KNN), support vector machine (SVM), and a three dimensional convolutional neural network set for comparison. Totally, 515 patients with or without COVID-19 between December 2019 and March 2020 from five different hospitals were recruited and divided into relatively large (150 COVID-19 and 183 CAP cases) and relatively small datasets (17 COVID-19 and 35 CAP cases) for either training or validation and another independent dataset (37 COVID-19 and 93 CAP cases) for external test. Area under the receiver operating characteristic curve (AUC), sensitivity, specificity, precision, accuracy, F1 score, and G-mean were utilized for performance evaluation.

resultsIn the external test cohort, the relatively large data-based 3DMTM-LD achieved an AUC of 0.956 (95% confidence interval, 95% CI, 0.929∼0.982) with 86.2% and 98.0% for its sensitivity and specificity. 3DMTM-SD got an AUC of 0.937 (95% CI, 0.909∼0.965), while the AUC of 3DCM-SD decreased dramatically to 0.714 (95% CI, 0.649∼0.780) with training data reduction. KNN-MMSD, LR-MMSD, SVM-MMSD, and 3DCM-MMSD benefited significantly from the inclusion of clinical information while models trained with relatively large dataset got slight performance improvement in COVID-19 discrimination. 3DMTM, trained with either CT or multi-modal data, presented comparably excellent performance in COVID-19 discrimination.

conclusionsThe 3DMTM algorithm presented excellent robustness for COVID-19 discrimination with limited CT data. 3DMTM based on CT data performed comparably in COVID-19 discrimination with that trained with multi-modal information. Clinical information could improve the performance of KNN, LR, SVM, and 3DCM in COVID-19 discrimination, especially in the scenario with limited data for training.

Indexed as

COVID-19Deep LearningPneumoniaArtificial IntelligenceCOVID-19 TestingHumansRetrospective StudiesSARS-CoV-2artificial intelligencecoronavirus disease 2019deep learningspiral computedtomography

Identifiers

PMID35305027
PMCPMC9088453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.